Tealwood Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.78M | Sell |
4,919
-22
| -0.4% | -$7.53K | 0.68% | 69 |
|
|
2026
Q1 | $1.74M | Buy |
4,941
+18
| +0.4% | +$6.42K | 0.79% | 59 |
|
|
2025
Q4 | $1.61M | Sell |
4,923
-24
| -0.5% | -$7.61K | 0.72% | 70 |
|
|
2025
Q3 | $1.4M | Sell |
4,947
-169
| -3% | -$49K | 0.56% | 91 |
|
|
2025
Q2 | $1.43M | Sell |
5,116
-118
| -2% | -$33.4K | 0.64% | 81 |
|
|
2025
Q1 | $1.63M | Sell |
5,234
-41
| -0.8% | -$12.1K | 0.76% | 59 |
|
|
2024
Q4 | $1.38M | Sell |
5,275
-34
| -0.6% | -$10.1K | 0.57% | 84 |
|
|
2024
Q3 | $1.71M | Buy |
5,309
+70
| +1% | +$22.9K | 0.75% | 55 |
|
|
2024
Q2 | $1.64M | Sell |
5,239
-38
| -0.7% | -$11.2K | 0.99% | 44 |
|
|
2024
Q1 | $1.5M | Buy |
5,277
+64
| +1% | +$18.7K | 0.68% | 71 |
|
|
2023
Q4 | $1.5M | Sell |
5,213
-69
| -1% | -$18.8K | 0.72% | 64 |
|
|
2023
Q3 | $1.42M | Buy |
5,282
+107
| +2% | +$26.7K | 0.73% | 59 |
|
|
2023
Q2 | $1.15M | Sell |
5,175
-11
| -0.2% | -$2.55K | 0.56% | 93 |
|
|
2023
Q1 | $1.25M | Sell |
5,186
-135
| -3% | -$33.1K | 0.64% | 74 |
|
|
2022
Q4 | $1.4M | Sell |
5,321
-184
| -3% | -$49.3K | 0.73% | 57 |
|
|
2022
Q3 | $1.24M | Sell |
5,505
-24
| -0.4% | -$5.82K | 0.67% | 61 |
|
|
2022
Q2 | $1.34M | Sell |
5,529
-31
| -0.6% | -$7.6K | 0.67% | 59 |
|
|
2022
Q1 | $1.34M | Sell |
5,560
-4
| -0.1% | -$919 | 0.57% | 79 |
|
|
2021
Q4 | $1.25M | Sell |
5,564
-253
| -4% | -$53.4K | 0.5% | 102 |
|
|
2021
Q3 | $1.24M | Buy |
+5,817
| New | +$1.34M | 0.5% | 98 |
|
|
2021
Q1 | $1.41M | Sell |
5,657
-35
| -0.6% | -$8.35K | 0.56% | 76 |
|
|
2020
Q4 | $1.31M | Buy |
5,692
+1,284
| +29% | +$296K | 0.62% | 78 |
|
|
2020
Q3 | $1.12M | Buy |
4,408
+33
| +0.8% | +$8.18K | 0.73% | 52 |
|
|
2020
Q2 | $1.03M | Buy |
4,375
+102
| +2% | +$23.3K | 0.69% | 58 |
|
|
2020
Q1 | $866K | Buy |
+4,273
| New | +$933K | 0.49% | 73 |
|
|
2017
Q3 | – | Sell |
-11,657
| Closed | -$2.01M | – | 100 |
|
|
2017
Q2 | $2.01M | Sell |
11,657
-89
| -0.8% | -$14.5K | 0.75% | 56 |
|
|
2017
Q1 | $1.93M | Sell |
11,746
-167
| -1% | -$27.7K | 0.76% | 55 |
|
|
2016
Q4 | $1.74M | Buy |
11,913
+251
| +2% | +$37.8K | 0.72% | 60 |
|
|
2016
Q3 | $1.95M | Sell |
11,662
-426
| -4% | -$72K | 0.86% | 53 |
|
|
2016
Q2 | $1.84M | Buy |
12,088
+237
| +2% | +$36.8K | 0.83% | 56 |
|
|
2016
Q1 | $1.78M | Sell |
11,851
-1,590
| -12% | -$236K | 0.8% | 55 |
|
|
2015
Q4 | $2.05M | Sell |
13,441
-895
| -6% | -$141K | 0.96% | 49 |
|
|
2015
Q3 | $1.98M | Sell |
14,336
-58
| -0.4% | -$9.14K | 0.87% | 58 |
|
|
2015
Q2 | $2.21M | Buy |
14,394
+1,960
| +16% | +$314K | 0.86% | 57 |
|
|
2015
Q1 | $1.99M | Sell |
12,434
-302
| -2% | -$47.6K | 0.81% | 57 |
|
|
2014
Q4 | $2.03M | Sell |
12,736
-299
| -2% | -$46.6K | 0.8% | 53 |
|
|
2014
Q3 | $1.83M | Buy |
13,035
+140
| +1% | +$18.3K | 0.72% | 57 |
|
|
2014
Q2 | $1.53M | Sell |
12,895
-185
| -1% | -$21.4K | 0.62% | 66 |
|
|
2014
Q1 | $1.61M | Buy |
13,080
+125
| +1% | +$15.2K | 0.65% | 66 |
|
|
2013
Q4 | $1.48M | Buy |
12,955
+155
| +1% | +$17.6K | 0.59% | 71 |
|
|
2013
Q3 | $1.43M | Buy |
12,800
+85
| +0.7% | +$9.22K | 0.63% | 66 |
|
|
2013
Q2 | $1.25M | Buy |
+12,715
| New | +$1.32M | 0.63% | 62 |
|
Other funds holding AMGN
Tealwood Asset Management's AMGN Position: Q2 2026 in Review
Tealwood Asset Management reduced its Amgen (AMGN) stake by 0.45% in Q2 2026, selling an estimated $7.53K and leaving 4,919 shares worth $1.78M. The position accounts for 0.68% of the portfolio, ranked #69.
Tealwood Asset Management first reported a position in AMGN in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.21M in Q2 2015. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Tealwood Asset Management held 4,919 shares of Amgen worth $1.78M as of Q2 2026.
- Tealwood Asset Management sold 22 Amgen shares in Q2 2026, an estimated $7.53K.
- Amgen made up 0.68% of Tealwood Asset Management's portfolio in Q2 2026, its #69 holding.
- Tealwood Asset Management first reported a position in Amgen in Q2 2013 and has held it in 42 quarters since.
- Tealwood Asset Management's Amgen position peaked at $2.21M in Q2 2015.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.